Sabra Health Care REIT, Inc.
SBRA
$17.47
-$0.03-0.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 381.50M | 378.46M | 376.99M | 372.17M | 376.27M |
| Total Other Revenue | 322.04M | 304.76M | 289.00M | 278.11M | 268.35M |
| Total Revenue | 703.54M | 683.22M | 665.99M | 650.28M | 644.62M |
| Cost of Revenue | 226.52M | 216.32M | 207.12M | 201.70M | 195.44M |
| Gross Profit | 477.02M | 466.90M | 458.87M | 448.59M | 449.18M |
| SG&A Expenses | 50.07M | 53.71M | 52.07M | 48.86M | 47.47M |
| Depreciation & Amortization | 169.62M | 170.19M | 170.71M | 173.17M | 183.09M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 446.21M | 440.23M | 429.91M | 423.73M | 426.00M |
| Operating Income | 257.33M | 243.00M | 236.09M | 226.55M | 218.62M |
| Income Before Tax | 127.72M | 98.29M | 54.12M | 51.22M | 15.76M |
| Income Tax Expenses | 1.01M | 1.12M | 1.84M | 1.73M | 2.00M |
| Earnings from Continuing Operations | 126.71 | 97.17 | 52.28 | 49.50 | 13.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 126.71M | 97.17M | 52.28M | 49.50M | 13.76M |
| EBIT | 257.33M | 243.00M | 236.09M | 226.55M | 218.62M |
| EBITDA | 422.09M | 407.37M | 400.98M | 393.91M | 395.89M |
| EPS Basic | 0.54 | 0.42 | 0.23 | 0.21 | 0.06 |
| Normalized Basic EPS | 0.38 | 0.34 | 0.32 | 0.30 | 0.28 |
| EPS Diluted | 0.53 | 0.41 | 0.21 | 0.20 | 0.05 |
| Normalized Diluted EPS | 0.38 | 0.34 | 0.32 | 0.30 | 0.28 |
| Average Basic Shares Outstanding | 933.96M | 928.59M | 925.52M | 925.11M | 924.82M |
| Average Diluted Shares Outstanding | 943.80M | 937.36M | 931.54M | 930.03M | 927.83M |
| Dividend Per Share | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
| Payout Ratio | 221.09% | 286.65% | 531.00% | 560.72% | 2,016.92% |